SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Nutrien Ltd. (NTR) trades at a trailing P/E of 16.0, forward P/E of 14.0. Trailing earnings yield is 6.27%, forward earnings yield 7.12%. PEG 0.06 (Peter Lynch undervalued ≤1.0). Graham Number is $74.46.
Criteria proven by this page:
- VALUE (80/100, Pass) — P/E is below market average (16.0); PEG ≤ 1.0 — Peter Lynch undervalued (0.06); analyst target implies upside (+14.1%); earnings yield beats bond yields (6.27%).
- Forward P/E 14.0 (down from trailing 16.0) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.06 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 6.27% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 7.12% as earnings recover.
- Analyst consensus target $84.00 (+14.1% upside) — modest upside expected.
Overall SharesGrow Score: 63/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
80/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — NTR
Valuation Multiples
P/E (TTM)16.0
Forward P/E14.0
PEG Ratio0.06
Forward PEG1.32
P/B Ratio1.43
P/S Ratio1.35
EV/EBITDA7.9
Per Share Data
EPS (TTM)$4.70
Forward EPS (Est.)$5.24
Book Value / Share$52.42
Revenue / Share$55.69
FCF / Share$4.11
Yields & Fair Value
Earnings Yield6.27%
Forward Earnings Yield7.12%
Dividend Yield2.91%
Graham Number$74.46
SharesGrow IV$30.33 (-58.8%)
Analyst Target$84.00 (+14.1%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
54.7 |
-0.74 |
2.24 |
4.12 |
4.40% |
| 2017 |
56.3 |
-28.13 |
2.22 |
4.05 |
1.79% |
| 2018 |
8.2 |
0.02 |
1.19 |
1.48 |
3.27% |
| 2019 |
28.1 |
-0.40 |
1.22 |
1.39 |
3.66% |
| 2020 |
59.8 |
-1.17 |
1.23 |
1.31 |
3.75% |
| 2021 |
13.6 |
0.02 |
1.81 |
1.55 |
2.44% |
| 2022 |
5.1 |
0.03 |
1.52 |
1.04 |
2.62% |
| 2023 |
22.2 |
-0.27 |
1.11 |
0.96 |
3.69% |
| 2024 |
32.8 |
-0.71 |
0.91 |
0.85 |
4.79% |
| 2025 |
13.0 |
0.05 |
1.19 |
1.10 |
3.60% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.00 |
$4.46B |
$336M |
7.5% |
| 2017 |
$0.98 |
$4.55B |
$327M |
7.2% |
| 2018 |
$5.72 |
$19.64B |
$3.57B |
18.2% |
| 2019 |
$1.74 |
$20.02B |
$992M |
5% |
| 2020 |
$0.85 |
$20.91B |
$459M |
2.2% |
| 2021 |
$5.47 |
$27.71B |
$3.15B |
11.4% |
| 2022 |
$13.62 |
$37.88B |
$7.66B |
20.2% |
| 2023 |
$2.53 |
$28.08B |
$1.26B |
4.5% |
| 2024 |
$1.36 |
$25.02B |
$674M |
2.7% |
| 2025 |
$4.74 |
$27.36B |
$2.31B |
8.4% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$5.14 |
$4.54 – $5.75 |
$26.73B |
$24.86B – $33.97B |
11 |
| 2027 |
$4.93 |
$3.93 – $5.58 |
$26.68B |
$25.21B – $29.11B |
11 |
| 2028 |
$4.75 |
$3.99 – $5.52 |
$26.6B |
$26.57B – $26.8B |
3 |
| 2029 |
$4.54 |
$4.19 – $5.35 |
$27.18B |
$25.65B – $30.99B |
1 |
| 2030 |
$4.95 |
$4.57 – $5.82 |
$27.43B |
$25.89B – $31.28B |
1 |
